Page last updated: 2024-10-21

4-aminopyridine and Spastic Paraplegia, Hereditary

4-aminopyridine has been researched along with Spastic Paraplegia, Hereditary in 2 studies

Spastic Paraplegia, Hereditary: A group of inherited diseases that share similar phenotypes but are genetically diverse. Different genetic loci for autosomal recessive, autosomal dominant, and x-linked forms of hereditary spastic paraplegia have been identified. Clinically, patients present with slowly progressive distal limb weakness and lower extremity spasticity. Peripheral sensory neurons may be affected in the later stages of the disease. (J Neurol Neurosurg Psychiatry 1998 Jan;64(1):61-6; Curr Opin Neurol 1997 Aug;10(4):313-8)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Selcuk Muhtaroglu, F1
Belgen Kaygisiz, B1
Usar Incirli, S1
Kahraman, T1
Béreau, M1
Anheim, M1
Chanson, JB1
Tio, G1
Echaniz-Laguna, A1
Depienne, C1
Collongues, N1
de Sèze, J1

Trials

1 trial available for 4-aminopyridine and Spastic Paraplegia, Hereditary

ArticleYear
Dalfampridine as a promising agent in the management of hereditary spastic paraplegia: A triple-blinded, randomized, placebo-controlled pilot trial.
    Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia, 2023, Volume: 117

    Topics: 4-Aminopyridine; Humans; Muscle Spasticity; Pilot Projects; Spastic Paraplegia, Hereditary; Walking

2023

Other Studies

1 other study available for 4-aminopyridine and Spastic Paraplegia, Hereditary

ArticleYear
Dalfampridine in hereditary spastic paraplegia: a prospective, open study.
    Journal of neurology, 2015, Volume: 262, Issue:5

    Topics: 4-Aminopyridine; Adult; Aged; Alkaloids; Analysis of Variance; Female; Follow-Up Studies; Humans; Ma

2015